|
|
Extended release allows for effective single-dose treatment, without doubling or tripling of drug concentration
|
|
|
Gynazole·1 stays at the site of the infection for a median of 4.2 days, resulting in minimal leakage2
|
|
|
One anytime dose and less mess for increased compliance3,4 |
|
|
The only single-dose cream that can be administered any time of the day or night2,5 |
|
|
Prefilled disposable applicator for easy dosing, less mess, and less hassle
|
|
Gynazole·1
is indicated for the local treatment of vulvovaginal candidiasis (infections caused
by Candida). The diagnosis should be confirmed by KOH smears and/or cultures. Note:
Gynazole·1 is safe and effective in non-pregnant women; however, the safety and
effectiveness of this product in pregnant women has not been established. |
|
|
|